Phoenix Children’s Hospital has entered into a commercial licensing agreement with NantHealth to adopt GPS Cancer, a comprehensive molecular testing platform for personalized cancer therapy for its patients and self-insured employee population.
As part of the licensing agreement, Phoenix will deploy the GPS Cancer in two key ways:
1. Its network of oncologists will be able to order GPS Cancer, enabling them to gain critical insights to inform personalized treatment strategies including guided chemotherapies, FDA-approved targeted drugs, and active clinical trials for their pediatric cancer patients.
2. Phoenix Children’s Hospital will cover GPS Cancer for its employees and their families, making it one of the nation’s first self-insured employers to cover proteogenomic sequencing for a variety of cancers.
NantHealth Solution Deployment Overview
The integration of GPS Cancer will allow Phoenix Children’s Hospital to be able to more easily manage and coordinate care for its patient population, thereby helping to improve engagement, reduce costs, and deliver on value-based outcomes. NantHealth’s solutions to be deployed at Phoenix Children’s Hospital include those for:
– Oncology decision support: Through the eviti decision support platform, oncologists will have access to evidence-based regimens, condition-specific clinical trials options, and capabilities to streamline preauthorization in advance of cancer treatments. With eviti, Phoenix Children’s joins over 75 percent of U.S. oncology practices who have adopted eviti platform to make better clinical decisions earlier in the treatment process.
– Patient engagement: With the NantHealth Patient Portal, patients will be able to access test results, expedite appointment scheduling, and securely communicate with Phoenix Children’s Hospital doctors through a web-based interface, enabling them to be more fully engaged with their care teams. In addition, the Health Heritage web application will allow patients to easily collect and share their family health histories with families and providers to improve care decision-making.
– Care coordination: The NantHealth Provider Portal will equip Phoenix Children’s Hospital providers with unified access to a 360° view of the patient across disparate locations and episodes of care. Through the NantHealth Referral Management app, doctors and administrators will be able to transform a tedious referral processes into a streamlined workflow connecting multiple sources of information and facilities into a single referral resource. Finally, the NantHealth Care Coordination app will help enable seamless collaboration across care settings, including post-discharge care coordination, urgent care triage, wellness programs, and transition of care.
– Analytics and Clinical Learning: NantHealth’s analytics and clinical learning solutions, including the and NantHealth Value Monitor applications, will enable Phoenix Children’s Hospital to measure and monitor key provider performance metrics to drive continuous improvement initiatives through rich dashboards.
“NantHealth’s GPS Cancer test and expansive healthcare IT portfolio provides us with the rich set of clinical and technical solutions to deliver the most advanced care possible for our patients,” said Robert L. Meyer, President and CEO, Phoenix Children’s Hospital in a statement. “With GPS Cancer, our network of oncologists will be able to gain insight into the most appropriate, personalized cancer therapies before treatment begins, while NantHealth’s oncology decision support, patient engagement, and care coordination solutions will help our care teams become more efficient—in service of our patients—as we continue to move into a value-based world.”
“In addition, our organization’s commitment to utilizing the GPS Cancer test for our employees, and their loved ones who may be facing cancer diagnoses, is important to us as we work to discover new potential therapies and clinical trials for cancer patients in our community.”
